OTCQB: LXXGF | TSX.V: LXG

BioSpace Coverage on LexaGene EUA Studies

by | Jan 18, 2021 | Biologics Manufacturing

Home » Biologics Manufacturing » BioSpace Coverage on LexaGene EUA Studies

Read BioSpace’s recent coverage of LexaGene’s plans to submit for FDA Emergency Use Authorization, and how the MiQLab™ system is ideally suited to test for COVID-19 variants at point-of-care.

Read the Full Article Here

<a href="https://lexagene.com/author/lexagene-admin/" target="_self">LexaGene</a>

LexaGene

LexaGene is a molecular diagnostics company that has commercialized the MiQLab System for fast and easy detection of biological contaminants, pathogens and other molecular markers.

The Value of a Filter-Based Sample Preparation Cartridge Used in a PCR Device for Sensitive and Rapid Detection of Contaminants

LexaGene’s MiQLab™ System is the only fully automated system on the market today that is equipped with a disposable filter-based sample preparation cartridge that allows for efficient processing of large volumes of sample for sensitive detection of contaminants.

Read More

Survey Says Veterinarians Have an Appetite for In-Clinic Diagnostic Technology

This spring LexaGene conducted a market research survey in conjunction with AAHA to assess the opinions of practicing veterinarians on AMR stewardship and the use of antibiotics in the treatment of companion animals.

Read More

The Dawn of the Superbugs

The most menacing of all resistant bacteria are the so called “super bugs”- strains of bacteria that are resistant to several different classes of antibiotics or multidrug resistant.

Read More
Subscribe for Updates

Upcoming Events

No events in this category to show at this time.

See All Events

Latest Resources

Application Note: Rapid Detection of Slow-growing Anaerobe Using MiQLab™ System


In this study, slow-growing bacterium and typical contaminant, C. acnes, was challenged for microbial detection utilizing both LexaGene’s MiQLab System and anaerobic culture.
1 2 3 4

See All Resources